The next dimension
of testing
VitroScreen, a SenzaGen Group company, pioneers next-generation in vitro testing solutions. We leverage cutting-edge biological models—from 2D cells and reconstructed tissues to ex vivo systems and cellular spheroids—to deliver precise, human-relevant data for the Cosmetics, Medical devices, Nutraceuticals, Pharma and Chemicals industries.

We bring science and ethics together to create meaningful, future-oriented testing solutions.
Scientific integrity
We uphold scientific integrity through rigorous, reproducible, trustworthy outcomes.
Human-relevant innovation
Our models mirror human biology for precise, predictive accuracy.
Client-centered approach
Tailored methodologies aligned with individual client specifications.
Validated process transparency
Certified, traceable processes ensure study integrity.
VitroScreen, a longstanding leader in sophisticated in vitro assays, propels the transition from animal-based paradigms to human-relevant models with unwavering ethical commitment. Integration with SenzaGen has amplified our technological prowess and international footprint, enabling delivery of expansive, high-fidelity services. This alliance fortifies our vanguard role in non-animal testing innovation.

Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Our industries
Medical devices
Cosmetics
Nutraceuticals
Pharma
Chemicals
Medical devices
Cosmetics
Nutraceuticals
Pharma
Chemicals
Medical devices
Cosmetics
Nutraceuticals
Pharma
Chemicals
Medical devices
Cosmetics
Nutraceuticals
Pharma
Chemicals
Medical devices
Cosmetics
Nutraceuticals
Pharma
Chemicals
Medical devices
Cosmetics
Nutraceuticals
Pharma
Chemicals
Medical devices
Cosmetics
Nutraceuticals
Pharma
Chemicals
Medical devices
Cosmetics
Nutraceuticals
Pharma
Chemicals
Medical devices
Cosmetics
Nutraceuticals
Pharma
Chemicals
We design and execute rigorous preclinical in vitro studies, combining validated testing standards with fully customized protocols to deliver reproducible, decision-ready results. Our expertise covers multiple product categories and therapeutic areas, providing highly predictive platforms for both regulatory and efficacy assessment.



Explore our latest research, scientific contributions, and industry insights shaping the future of advanced in vitro science.
Our news
All NewsDrag
Webinar – Beyond the Drop – Safety and Biocompatibility Challenges of Ophthalmic Medical Devices
19 November 2025
Webinar – Assessing the mechanism of action of substance-based medical devices via novel in-vitro tools
12 November 2025
3rd annual Medical Device Biocompatibility conference
6–7 November 2025
Berlin, Germany
A scientific conference focused on biocompatibility, safety, and regulatory aspects of medical devices.
CPHI 2025
28–30 October 2025
Frankfurt, Germany
One of the leading European events for the pharmaceutical and medical device industries.
Cosmetic 360
15–16 October 2025
Paris, France
A European event dedicated to cosmetic innovation and the start-up ecosystem.
IFSCC 2025
15–18 September 2025
Cannes, France
An international scientific congress focused on cosmetic research, innovation, and advanced studies.
Vitafoods Europe 2025
20–22 May 2025
Europe
A global event dedicated to the nutraceutical and food supplement industry.
in-cosmetics Global 2025
7–8 April 2025
Amsterdam, The Netherlands
A global exhibition focused on cosmetic ingredients, raw materials, and innovation.
Cosmoprof Worldwide Bologna 2025
21 March 2025
Bologna, Italy
A leading international trade fair dedicated to the cosmetics industry and finished beauty products.
SOT 2025 – 64th Annual Meeting
16–20 March 2025
Orlando, Florida (USA)
Scientific participation in a leading international toxicology congress with a poster in collaboration with Procter & Gamble.
ESTIV 2024
3 – 6 June 2024
Prague – Czech Republic
Mark your calendars for VitroScreen's two presentations at the ESTIV gathering in Prague from June 3-6, 2024.
Our publications
All publicationsDrag
Film Forming on Esophageal Epithelium - MD: Evidence and Research
Mimicking Senescence Factors to Characterize the Mechanisms Responsible for Hair Regression and Hair Loss: An In Vitro Study
Use of a 3D Model with Reconstructed Human Epidermis Infected with Fungi and Covered with a Bovine Nail to Simulate Onychomycosis and to Evaluate the Effects of Antifungal Agents
Targeted Antibacterial Endolysin to Treat Infected Wounds on 3D Full-Thickness Skin Model: XZ.700 Efficacy
Demonstrating the principal mechanism of action of medical devices intended for vaginal use on reconstructed human vaginal epithelium: the case of two hyaluronic acid-containing devices
Protective mechanism of butyrate and palmitoylethanolamide highlighted by VitroScreen ORA® - a new microphysiological system mimicking colon inflammation
Non Clinical Model to Assess the Mechanism of Action of a Combined Hyaluronic Acid, Chondroitin Sulfate and Calcium Chloride: HA+CS+CaCl2 Solution on a 3D Human Reconstructed Bladder Epithelium
Meeting report “VitroScreen seminar on SBMDs"
The Effect of Carnosine on UVA-Induced Changes in Intracellular Signaling of Human Skin Fibroblast Spheroids
Evaluation of Antimicrobial, Antiadhesive and Co-Aggregation Activity of a Multi-Strain Probiotic Composition against Different Urogenital Pathogens
New matrix to help the ocular surface in dry eye disease
Protective Mechanisms of Liquid Formulations for Gastro-Oesophageal Reflux Disease in a Human Reconstructed Oesophageal Epithelium Model
Proteomic study on human dermis spheroids
Validation of SkinEthic HCE Time-to-Toxicity test method for eye hazard classification
Barrier Impairment Associated with GERD
Immunocompetent DED model
Extra Cellular Matrix Deposition and Assembly in Dermis Spheroids
Reproducing the scalp microbiota on RHE_UCS
In vitro Comparison of Safety and Efficacy of Diluted Isotonic Seawater and Electrodialyzed Seawater for Nasal Hygiene
Red Carrot Cells as safe ingredient - Frontiers in Bioengineering and Biotechnology
In vitro evaluation of Seawater-based solutions
Microglycine on HCE - Clinical Ophthalmology
Dry eye disease treatment - European Review for Medical and Pharmacological Sciences
Hard Water on RHE - Dermatology Research
Adipose Microtissue - IFSCC
Inflammasome - IFSCC
Meeting report "Alternative Methods in science" - Altex
Meeting Reports - MDBiological Evaluation - Altex
MD Biocompatibility on HCE - Regulatory Toxicology and Pharmacology
Anti-Inflammaging Cosmetic Action on RHE - CUDP-100003
O/W Emulsions with Plant-Based Actives - Cosmetics
Microhair Follicle Model - Cosmetics
Regulation of Extracellular Matrix Genes by Amini Acid and HA - Journal of Biological Regulators & Homeostatic Agents
Irritant activity in MD Extracts - TIV
Film Forming Method - Regulatory Toxicology and Pharmacology
3D Human Tissue Models for Reproductive Biology - Current Trends in Clinical Embryology
Celltox Meeting report - Altex
Protective barrier properties on 3D airway tissue - Allergy, Asthma & Clinical Immunology
Dry Eyes Model - Current Eye Research
Escherichia Coli Invasion Model - Future Microbiology
Biofilm - Wounds
Models on liver - Altex
Dispositivi Medici ad uso topico - CT
Absorption of Berberine - IJDDT
Dispositivi Medici - Assorbimento Percutaneo in vitro - COSMETIC TECHNOLOGY
Dispositivi Medici - Assorbimento intestinale - L'integratore nutrizionale
Dispositivi Medici - Prodotti borderline - L'integrazione nutrizionale
Dispositivi Medici - Sicurezza - Cosmetic Technology
Modelli in vitro - L'integratore nutrizionale
Metodi alternativi - Cosmetics Technology


